NYU Langone Health

NYU Langone Health Develops Novel Tracheostomy Approach to Improve Patient Care and Reduce Risk of “Super-Spreading” Procedures

Newswise — Physicians at NYU Langone Health have developed a newer and perhaps safer approach to tracheostomy that addresses two important challenges: improve care for COVID-19 patients who require prolonged intubation and ventilator support, and reduce “super-spreading” events that pose a risk to healthcare workers.

Tracheostomy allows for easier removal of secretions from the airway, which has been a leading cause of death in prolonged intubated patients with COVID-19. In addition, it often results in less use of paralytic medications and affords patients the chance to be awake and alert, and to mobilize to maintain muscular strength. However, most prominent medical institutions and surgical organizations recommend against performing tracheostomies for two to three weeks, or until patients are less infectious, because the more conventional, open tracheostomy – often performed in the operating room – poses higher risk to healthcare workers because of increased exposure to secretions.

NYU Langone Health chose to deviate from the recommended pathway, believing that COVID-19 patient care is maximized with early tracheostomy – just like they had seen with other non-COVID patients on ventilators for long periods of time.

“We were determined to find a way to perform early tracheostomies that were not super spreading events, and that would provide our patients the optimal care they needed as soon as possible,” said Robert J. Cerfolio, MD, executive vice president and chief of Hospital Operations at NYU Langone Health, and Division Chief of Clinical Thoracic Surgery. “We believe we have found a way to accomplish both.” 

How the New Approach to Tracheostomy Works

The new procedure, led by Luis Angel, MD, medical director of Lung Transplantation at NYU Langone Health, and Zachary Kon, MD, surgical director of Lung Transplantation, is principally based on the position of the bronchoscope to the endotracheal tube, which patients use to breathe. Instead of going directly into the endotracheal tube, as it done in most conventional tracheostomies, the new procedure allows the bronchoscope to be placed in the patient’s airway, just above the endotracheal tube. “This prevents the patient’s secretions from blowing into the air and exposing healthcare workers to infectious discharges,” Angel said.

The procedure is performed in about five minutes at the patient’s bedside – reducing added risk of going to the operating room to have it performed. At the same time, the procedure provides a greater opportunity to more quickly wean patients off ventilators and paralytic agents used to sedate and immobilize them. This, in turn, gives patients an improved opportunity to re-build lung and muscle capacity in order to mobilize and eventually return home. 

Results to Date

NYU Langone Health has performed over 40 of these novel percutaneous tracheostomies, with many more expected in the coming weeks. While it is too soon to prove impact on survival, all patients that have had this new procedure performed are alive and most are making faster improvements than others, including being weaned off ventilators.

“No NYU Langone patient who received this procedure has been lost and there have been no significant complications,“ Kon added. “Importantly, no NYU Langone healthcare providers present during this new technique have become ill.”  

Cerfolio added that improving patient care was originally the only reason to adopt this new technique. However, they have yielded secondary advantages, including removing patients sooner from ventilators, thus freeing them up for other patients, and reducing the use of paralytic agents, which are in low supply. He also pointed out that more than 20 academic medical centers across the country have reached out to learn how to perform the new procedure at their hospitals.

While more mature and robust data is needed, Cerfolio said this novel concept is reaping significant and promising dividends for patient outcomes. “The fact that we are seeing early benefits is a significant clinical milestone,” he added.  “We continue to look for new ways to battle this insidious illness.”

Filters close

Showing results

1120 of 3765
Newswise: Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Released: 23-Oct-2020 10:40 AM EDT
Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Michigan Medicine - University of Michigan

What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Oct-2020 11:00 AM EDT Released to reporters: 23-Oct-2020 8:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Oct-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Released: 22-Oct-2020 2:40 PM EDT
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
University of Maryland Medical Center

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 22-Oct-2020 2:25 PM EDT
Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
Massachusetts General Hospital

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH).

Released: 22-Oct-2020 2:10 PM EDT
New York Gov. Andrew Cuomo said that nursing homes "never needed" to accept patients who tested positive for COVID-19, but they did accept them

According to a report from the New York State Department of Health, "6,326 COVID-positive residents were admitted to [nursing home] facilities" following Cuomo's mandate that nursing homes accept the readmission of COVID-positive patients from hospitals. Therefore we rate his claim as false.

Released: 22-Oct-2020 2:10 PM EDT
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

Newswise: UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
Released: 22-Oct-2020 1:50 PM EDT
UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
University of Nevada, Las Vegas (UNLV)

As the race for a COVID-19 vaccine intensifies, health care officials are reminding the public not to forget another important vaccine this fall: the flu shot. Flu season in the U.S. technically began in September, with illnesses expected to peak in December and February, according to the Centers for Disease Control (CDC). Less than half of Americans received a flu vaccine during the 2019-2020 flu season, and a staggering 405,000 hospitalizations and 22,000 deaths were attributed to influenza.

Newswise: 246630_web.jpg
Released: 22-Oct-2020 1:45 PM EDT
Immune response the probable underlying cause of neural damage in COVID-19
University of Gothenburg

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

Released: 22-Oct-2020 1:35 PM EDT
COVID-19 study: Meaning in life and self-control protect against stress
University of Innsbruck

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

Newswise: Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Released: 22-Oct-2020 1:30 PM EDT
Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Hackensack Meridian Health

A new portable “lab on a chip,” developed by the U-M scientists and demonstrated with help of the CDI, can identify the presence of COVID-19 antibodies in blood donors with greater speed and efficiency

Showing results

1120 of 3765